Otto Schwarz is joining Actelion SA of Switzerland as head of business operations, effective 14 January 2008, succeeding Christian Chavy. Mr Chavy is leaving the company to pursue other opportunities.
Mr Schwarz was previously executive vice-president for commercial operations at Nycomed where he supervised business in more than 40 countries. An Austrian national with a Ph.D in pharmaceutical chemistry, Mr Schwarz has worked for more than 20 years in the pharmaceutical industry.
Actelion is a biopharmaceutical company whose first drug, Tracleer, has been approved as a therapy for pulmonary arterial hypertension.
Source:
Actelion Pharmaceuticals press release, 30 November 2007
Copyright 2007 Evernow Publishing Ltd